F Gilead Sciences, Inc. Transaction History

F

$2.83 Billion
Q3 2024

A detailed history of F transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, F holds 2,535 shares of GILD stock, worth $238,568. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,535

Holding current value

$238,568

% of portfolio

0.01%

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	BUY	$66.59 - $83.99 $168,805 - $212,914	2,535 New	2,535 $212,000
Q2 2021 Aug 10, 2021	SELL	$63.47 - $69.35 $256,545 - $280,312	-4,042 Closed	0 $0
Q1 2021 Jun 01, 2021	BUY	$60.0 - $68.46 $242,520 - $276,715	4,042 New	4,042 $261,000

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.4 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.9 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.2 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.82 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.66 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of F, based on Form 13F filings with the SEC.

News

Stay updated on F with notifications on news.

Account